Armata Pharmaceuticals (ARMP) Share-based Compensation (2013 - 2026)
Armata Pharmaceuticals (ARMP) posted Share-based Compensation of $11000.0 for Q1 2026, up 100.57% sequentially from -$1.9 million in Q4 2025, and down 98.59% YoY from $781000.0 in Q1 2025.
Armata Pharmaceuticals (ARMP) Share-based Compensation (2013 - 2026) Analysis & Trends
Armata Pharmaceuticals has reported Share-based Compensation for 14 years, with the latest figure at $11000.0 in Q1 2026.
- Quarterly Share-based Compensation fell 98.59% year-over-year to $11000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$565000.0 (down 146.16% YoY) and the FY2025 annual result came in at $2.1 million, down 19.23% from the prior year.
- Share-based Compensation advanced to $11000.0 in Q1 2026 per ARMP's latest filing, from -$1.9 million in the prior quarter.
- Over five years, Share-based Compensation peaked at $2.7 million in Q3 2025 and troughed at -$1.9 million in Q4 2025.
- A 5-year average of $420882.4 and a median of $575000.0 in 2025 frame the typical range for Share-based Compensation.
- The widest YoY moves for Share-based Compensation: up 411.49% in 2024, down 909.33% in 2024.
- Over 5 years, Share-based Compensation stood at $817000.0 in 2022, then tumbled by 76.38% to $193000.0 in 2023, then plunged by 909.33% to -$1.6 million in 2024, then retreated by 23.69% to -$1.9 million in 2025, then surged by 100.57% to $11000.0 in 2026.
- According to Business Quant data, Share-based Compensation over the past three periods registered $11000.0, -$1.9 million, and $2.7 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | 108.10 Mn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 243.00 Mn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | - |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | 120.00 Mn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 137.41 Mn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 86.63 Mn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | 41.25 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | - |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | 28.05 Mn |
| 10 | Armata Pharmaceuticals | 162.98 Mn | 138.98 Mn | - | 3.39 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 3.39 Mn |
| Jun 30, 2026 | 3.39 Mn |
| Mar 31, 2026 | 11,000.00 |
| Mar 31, 2026 | 11,000.00 |
| Dec 31, 2025 | -1.93 Mn |
| Dec 31, 2025 | -1.93 Mn |
| Sep 30, 2025 | 2.70 Mn |
| Sep 30, 2025 | 2.70 Mn |
| Jun 30, 2025 | 575,000.00 |
| Jun 30, 2025 | 575,000.00 |
| Mar 31, 2025 | 781,000.00 |
| Mar 31, 2025 | 781,000.00 |
| Dec 31, 2024 | -1.56 Mn |
| Dec 31, 2024 | -1.56 Mn |
| Sep 30, 2024 | 670,000.00 |
| Sep 30, 2024 | 670,000.00 |
| Jun 30, 2024 | 1.34 Mn |
| Jun 30, 2024 | 1.34 Mn |
| Mar 31, 2024 | 534,000.00 |
| Mar 31, 2024 | 534,000.00 |